Project Details

Project Submission No.	S00497
Project Title	20 MW Solar Power Project by M/s Sun Pharmaceutical Industries Limited
Project Owner(s) (as per PSF & LOA)	Sun Pharmaceutical Industries Limited
Submission Date	2022-06-28
Global Stakeholder Consultation Period	2022-10-10 to 2022-10-24
Sector	1.Energy industries (renewable-/non-renewable sources)
Project Type	Solar Power
GCC/CDM Methodology & Version	GCCM001 Methodology for Renewable Energy Generation Projects Supplying Electricity to Grid or Captive Consumers & version 3.0
Forecasted GHG Emission Reduction (tCO₂e/Year)	29,957
Forecasted E⁺ Label	Yes
Forecasted S⁺ Label	Yes
Forecasted SDG⁺ Goals
Forecasted SDG⁺ Label	Silver
Forecasted Market Eligibility	C+ - Pilot Phase

Location Details Open Full Map
Country	India
Focal Point of Project Owners	Sun Pharmaceutical Industries Limited
Email of Contact Person of FP (Primary)	jibanananda.mohapatra@sunpharma.com
Email of Contact Person of FP (Secondary)	rajendra.gadhe@sunpharma.com
Documents for Global Stakeholder Consultation	Project Submision Calculation Sheet Other Documents

Project Brief	The project activity is the installation of a new captive grid-connected 20 MW Solar power plant at the site where no renewable power plant was operating prior to the implementation of the project activity (green-field plant). The project activity is solar power project which is being implemented by M/s Sun Pharmaceutical Industries Limited. The annual average estimated emission reductions from project activity are 29,957 tCO2e/annum.

Project Brief

The project activity is the installation of a new captive grid-connected 20 MW Solar power plant at the site where no renewable power plant was operating prior to the implementation of the project activity (green-field plant). The project activity is solar power project which is being implemented by M/s Sun Pharmaceutical Industries Limited. The annual average estimated emission reductions from project activity are 29,957 tCO2e/annum.

PROJECT DETAILS